Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03218878 · ClinicalTrials.gov registry record
Pregnancy Outcomes After Uterine Cavity Expansion
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 9
- Enrollment target
NCT03218878: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT03218878 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03218878 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study seeks to evaluate pregnancy outcomes following hysteroscopic uterine cavity expansion surgery for patients with dysmorphic uterine cavities and poor reproductive histories. Patients already planning to undergo surgery at the recommendation of their physicians will be recruited for participation.
Primary Outcome
presence of a fetal heartbeat at 8 weeks gestation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2018-09-10 |
What the finished NCT03218878 record still lists
NCT03218878 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03218878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03218878 about?
NCT03218878 is a clinical study titled "Pregnancy Outcomes After Uterine Cavity Expansion". This study seeks to evaluate pregnancy outcomes following hysteroscopic uterine cavity expansion surgery for patients with dysmorphic uterine cavities and poor reproductive histories. Patients already planning to undergo surgery at the recommendation of their physicians will be recruited for partici...
What is the current status of trial NCT03218878?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2017-07-21. Estimated completion is 2018-09-10.
Who is sponsoring clinical trial NCT03218878?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI